Oxytocin and Resting State fMRI
Intranasal Oxytocin and Resting State fMRI in Healthy Volunteers
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The goal of the study is to investigate the effects of intranasal oxytocin (OT) or placebo to resting state brain activity in healthy males.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 16, 2016
CompletedFirst Posted
Study publicly available on registry
February 24, 2016
CompletedFebruary 24, 2016
February 1, 2016
1 year
February 16, 2016
February 18, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Resting state brain activity using fMRI
30min
Secondary Outcomes (1)
Subject personality using questionnaires
30min
Study Arms (2)
OT
ACTIVE COMPARATOROxytocin
Placebo
PLACEBO COMPARATORPlacebo
Interventions
Eligibility Criteria
You may qualify if:
- Health
You may not qualify if:
- Chronic physical or mental illness, regular smoking or alcohol consumption and medication intake
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Purpose
- BASIC SCIENCE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Investigator
Study Record Dates
First Submitted
February 16, 2016
First Posted
February 24, 2016
Study Start
October 1, 2014
Primary Completion
October 1, 2015
Last Updated
February 24, 2016
Record last verified: 2016-02